✦ LIBER ✦

PRS3 A MICROSIMULATION ECONOMIC MODEL TO EVALUATE THE DISEASE BURDEN ASSOCIATED WITH SMOKING IN ARGENTINA

✍ Scribed by Pichon-Riviere, A; Augustovski, FA; Colantonio, L; Bardach, A; Rubinstein, A

Book ID: 122410653
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 63 KB
Volume: 12
Category: Article
ISSN: 1098-3015
DOI: 10.1016/S1098-3015(10)75495-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development and Validation of a Microsim

Development and Validation of a Microsimulation Economic Model to Evaluate the Disease Burden Associated with Smoking and the Cost-Effectiveness of Tobacco Control Interventions in Latin America

✍ Andres Pichon-Riviere; Federico Augustovski; Ariel Bardach; Lisandro Colantonio 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 942 KB

Calibration of a Cost-Effectiveness Mode

Calibration of a Cost-Effectiveness Model to Evaluate the Incorporation of a Quadrivalent HPV Types 6, 11, 16, 18 Vaccine in Argentina: Disease Burden Component

✍ Pichon-Riviere, A.; Caporale, J.; Alcaraz, A.; Bardach, A.; Klein, K.; Rey Ares, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

A Markov Chain Model to Evaluate the Eff

A Markov Chain Model to Evaluate the Effect ofCYP3A5andABCB1Polymorphisms on Adverse Events Associated with Tacrolimus in Pediatric Renal Transplantation

✍ Sy, Sherwin K. B.; Heuberger, Jules; Shilbayeh, Sireen; Conrado, Daniela J.; Der 📂 Article 📅 2013 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 283 KB

P.5.c.001 A 3-year open-label, follow-up

P.5.c.001 A 3-year open-label, follow-up study to evaluate the efficacy and tolerability of sarizotan in Parkinson's disease patients with treatment-associated dyskinesia

✍ T. Müller 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 61 KB